[HTML][HTML] Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin, G Zhou… - Molecular cancer, 2017 - Springer
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.
X Huo, S Han, G Wu, O Latchoumanin… - Molecular …, 2017 - search.ebscohost.com
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
[引用][C] Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin… - Molecular Cancer …, 2017 - jglobal.jst.go.jp
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for
tumorigenesis, disease progression, and liver cancer stem cells | Article Information | J-GLOBAL …
tumorigenesis, disease progression, and liver cancer stem cells | Article Information | J-GLOBAL …
[PDF][PDF] Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin, G Zhou… - 2017 - core.ac.uk
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
[HTML][HTML] Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin, G Zhou… - Molecular …, 2017 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin… - Molecular …, 2017 - researchonline.jcu.edu.au
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
[HTML][HTML] Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu… - Molecular …, 2017 - molecular-cancer.biomedcentral …
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin, G Zhou… - Molecular …, 2017 - go.gale.com
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.
X Huo, S Han, G Wu, O Latchoumanin, G Zhou… - Molecular …, 2017 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin… - Molecular …, 2017 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor
prognosis worldwide. While early stage tumours can be treated with curative approaches …
prognosis worldwide. While early stage tumours can be treated with curative approaches …